Claro

Verify with FDA CVM →

100 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
100
Total Reports
20
Deaths Reported
2000.0%
Death Rate

Active Ingredients

Claro

Administration Routes

Auricular (Otic)UnknownTopicalOral

Species Affected

Dog 95
Cat 5

Most Affected Breeds

Retriever - Golden 11
Retriever - Labrador 11
Dog (unknown) 6
Boxer (German Boxer) 6
Crossbred Canine/dog 5
Terrier - Bull - American Pit 4
Beagle 4
Dog (other) 4
Shih Tzu 3
Pug 3

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 26
Vomiting 20
Death by euthanasia 15
Diarrhoea 14
Anorexia 13
Decreased appetite 10
Panting 9
Seizure NOS 9
Musculoskeletal disorder NOS 7
Unable to stand 7
Anaphylaxis 7
Fever 7

Outcome Breakdown

Ongoing
54 (53.5%)
Recovered/Normal
16 (15.8%)
Euthanized
15 (14.9%)
Outcome Unknown
10 (9.9%)
Died
5 (5.0%)
Recovered with Sequela
1 (1.0%)

Data Summary

Metric Value
Total adverse event reports 100
Reports involving death 20
Case-fatality rate (reported events) 2000.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Claro Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 100 adverse event reports referencing Claro, including 20 reports in which the animal died — a 2000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Claro. Reported administration routes include Auricular (Otic), Unknown, Topical, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Claro reports are Dog (95 reports), Cat (5 reports), with Dog accounting for the largest share. Within those species, Retriever - Golden (11), Retriever - Labrador (11), Dog (unknown) (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Claro are Lethargy (see also Central nervous system depression in Neurological) (26), Vomiting (20), Death by euthanasia (15), Diarrhoea (14). Of the 101 reports with a coded outcome, Ongoing is the leading category at 53.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Claro.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial